Elizabeth A. Conner

5.6k total citations · 3 hit papers
46 papers, 4.4k citations indexed

About

Elizabeth A. Conner is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Elizabeth A. Conner has authored 46 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Oncology and 12 papers in Hepatology. Recurrent topics in Elizabeth A. Conner's work include Cancer-related Molecular Pathways (15 papers), Liver physiology and pathology (11 papers) and RNA modifications and cancer (7 papers). Elizabeth A. Conner is often cited by papers focused on Cancer-related Molecular Pathways (15 papers), Liver physiology and pathology (11 papers) and RNA modifications and cancer (7 papers). Elizabeth A. Conner collaborates with scholars based in United States, South Korea and Germany. Elizabeth A. Conner's co-authors include Snorri S. Thorgeirsson, Valentina M. Factor, Diego F. Calvisi, Sara Ladu, Miriam Farina, Koichi Uchida, Jesper B. Andersen, Ju‐Seog Lee, Aranzazu Sánchez and Jens U. Marquardt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Elizabeth A. Conner

45 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte growth factor/c-metsignaling pathway is required for efficient liver regeneration and repair

2004 611 citations Valentina M. Factor, Koichi Uchida et al. profile →
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC

2006 558 citations Diego F. Calvisi, Sara Ladu et al. profile →
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors

2011 384 citations Jesper B. Andersen, Itzhak Avital et al. profile →

Peers

Elizabeth A. Conner

HEPAT

ONCOL

SURGE

Jin Ding China

Hayato Hikita Japan

Henning Schulze‐Bergkamen Germany

Jeonghoon Heo South Korea

Sabine Colnot France

Antonio Mazzocca Italy

Taisei Kinoshita Japan

Kaishan Tao China

Yoshitaka Hippo Japan

Patricia Sancho Spain

Jin Ding China

Elizabeth A. Conner

3.0k ×1.2

821 ×0.5

HEPAT

1.0k ×1.0

ONCOL

432 ×0.4

SURGE

2.0k ×2.2

Citations per year, relative to Elizabeth A. Conner Elizabeth A. Conner (= 1×) peers Jin Ding

Countries citing papers authored by Elizabeth A. Conner

Since Specialization

Citations

This map shows the geographic impact of Elizabeth A. Conner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Conner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Conner more than expected).

Fields of papers citing papers by Elizabeth A. Conner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Conner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Conner. The network helps show where Elizabeth A. Conner may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Conner

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Conner. A scholar is included among the top collaborators of Elizabeth A. Conner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Conner. Elizabeth A. Conner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yim, Sun Young, Jae‐Jun Shim, Ji-Hyun Shin, et al.. (2018). Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer. Molecular Cancer Research. 16(11). 1713–1723. 16 indexed citations

Marquardt, Jens U., Luis E. Gómez-Quiroz, Federico Pinna, et al.. (2015). Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. Journal of Hepatology. 63(3). 661–669. 227 indexed citations

Lee, Yun-Han, Daekwan Seo, Kyung‐Ju Choi, et al.. (2014). Antitumor Effects in Hepatocarcinoma of Isoform-Selective Inhibition of HDAC2. Cancer Research. 74(17). 4752–4761. 77 indexed citations

Masuda, Tomohiro, Xiaodong Zhang, Jun Wan, et al.. (2014). The Transcription Factor GTF2IRD1 Regulates the Topology and Function of Photoreceptors by Modulating Photoreceptor Gene Expression across the Retina. Journal of Neuroscience. 34(46). 15356–15368. 7 indexed citations

Kitade, Mitsuteru, Valentina M. Factor, Jesper B. Andersen, et al.. (2013). Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling. Genes & Development. 27(15). 1706–1717. 80 indexed citations

Marquardt, Jens U., Daekwan Seo, Luis E. Gómez-Quiroz, et al.. (2012). Loss of c-Met accelerates development of liver fibrosis in response to CCl4 exposure through deregulation of multiple molecular pathways. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(6). 942–951. 67 indexed citations

Marquardt, Jens U., Chiara Raggi, Jesper B. Andersen, et al.. (2011). Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. Hepatology. 54(3). 1031–1042. 63 indexed citations

Lee, Yun-Han, Jesper B. Andersen, Ho‐Taek Song, et al.. (2010). Definition of Ubiquitination Modulator COP1 as a Novel Therapeutic Target in Human Hepatocellular Carcinoma. Cancer Research. 70(21). 8264–8269. 60 indexed citations

Factor, Valentina M., Daekwan Seo, Tsuyoshi Ishikawa, et al.. (2010). Loss of c-Met Disrupts Gene Expression Program Required for G2/M Progression during Liver Regeneration in Mice. PLoS ONE. 5(9). e12739–e12739. 59 indexed citations

10.

Kaposi-Novák, Pál, Louis Libbrecht, Hyun Goo Woo, et al.. (2009). Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis. Cancer Research. 69(7). 2775–2782. 149 indexed citations

11.

Gómez-Quiroz, Luis E., Valentina M. Factor, Pál Kaposi-Novák, et al.. (2008). Hepatocyte-specific c-Met Deletion Disrupts Redox Homeostasis and Sensitizes to Fas-mediated Apoptosis. Journal of Biological Chemistry. 283(21). 14581–14589. 69 indexed citations

12.

Takami, Taro, Pál Kaposi-Novák, Koichi Uchida, et al.. (2007). Loss of Hepatocyte Growth Factor/c-Met Signaling Pathway Accelerates Early Stages of N -nitrosodiethylamine–Induced Hepatocarcinogenesis. Cancer Research. 67(20). 9844–9851. 80 indexed citations

13.

Calvisi, Diego F., Sara Ladu, Alexis Gorden, et al.. (2007). Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. Journal of Clinical Investigation. 117(9). 2713–2722. 313 indexed citations

14.

Calvisi, Diego F., Sara Ladu, Alexis Gorden, et al.. (2006). Molecular pathogenesis of human hepatocellular carcinoma: Mechanistic and prognostic significance of aberrant methylation. Cancer Research. 66. 763–763. 2 indexed citations

15.

Takami, Taro, et al.. (2006). Loss of HGF/c-met signaling pathway accelerates early stages of DEN-induced hepatocarcinogenesis. Cancer Research. 66. 84–84. 1 indexed citations

16.

Ladu, Sara, Diego F. Calvisi, Elizabeth A. Conner, Valentina M. Factor, & Snorri S. Thorgeirsson. (2005). Co-expression of c-Myc and E2F1 in a mouse model of liver cancer suppresses apoptosis through activation of Akt/mTOR/p70S6K and COX-2 pathways: relevance for human hepatocellular carcinoma. Cancer Research. 65. 258–258. 1 indexed citations

17.

Hironaka, Koji, Valentina M. Factor, Diego F. Calvisi, Elizabeth A. Conner, & Snorri S. Thorgeirsson. (2003). Dysregulation of DNA Repair Pathways in a Transforming Growth Factor α/c-myc Transgenic Mouse Model of Accelerated Hepatocarcinogenesis. Laboratory Investigation. 83(5). 643–654. 33 indexed citations

18.

Conner, Elizabeth A., Eric R. Lemmer, Masako Omori, et al.. (2000). Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene. 19(44). 5054–5062. 120 indexed citations

19.

Conner, Elizabeth A., T Teramoto, Peter J. Wirth, et al.. (1999). HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Carcinogenesis. 20(4). 583–590. 47 indexed citations

20.

Conner, Elizabeth A. & Peter J. Wirth. (1996). Protein alterations associated with gene amplification in cultured human and rodent cells. Electrophoresis. 17(7). 1257–1264. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact